A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers

Acellular dermal matrices can successfully heal wounds. This study's goal was to compare clinical outcomes of a novel, open‐structure human reticular acellular dermis matrix (HR‐ADM) to facilitate wound closure in non‐healing diabetic foot ulcers (DFUs) versus DFUs treated with standard of care...

Descripción completa

Detalles Bibliográficos
Autores principales: Zelen, Charles M, Orgill, Dennis P, Serena, Thomas, Galiano, Robert, Carter, Marissa J, DiDomenico, Lawrence A, Keller, Jennifer, Kaufman, Jarrod, Li, William W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949710/
https://www.ncbi.nlm.nih.gov/pubmed/27073000
http://dx.doi.org/10.1111/iwj.12600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949710/
https://www.ncbi.nlm.nih.gov/pubmed/27073000
http://dx.doi.org/10.1111/iwj.12600

Ejemplares similares